Intellectual Property Protection

Protecting our value through IP

Making an impact on the bottom line and people’s lives

AMADIX recognizes the importance of developing IP strategies early to determine how it could serve our long-term business interests. We capture the value of our innovation through strong patent protection.

Intellectual Property

Our Products

Innovation is revolutionizing cancer diagnosis.


PreveCol® is an innovative blood-based test for the early detection of colorectal cancer (CRC) or advanced adenomas (AA) and precancerous lesions. Based on an algorithm that combines clinical characteristics with an analysis of biomarkers present in the individual’s blood.

CE Marked


DiagnoLung® is an innovative blood-based test for the early detection of lung cancer. Non-invasive test that can be used for the diagnosis of lung cancer and as a screening tool in high-risk populations.

Under development


PancreaDix® is an innovative blood-based test for the detection of pancreatic cancer (ductal adenocarcinoma and preneoplastic lesions). Non-invasive test.

Under development

All our products have solid worldwide patent protection

AMADIX’s intellectual property

If you want to learn more, please contact us.

Open chat
Hello 👋
How can we assist you today?